Fanucci Marsha Insider Trades

Insider Trading History

Track insider trading activity for Fanucci Marsha. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $6.4 16,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 6,000 shares
$5.30
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $4.8 12,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2k 6,000 shares
$3.70
$0.00
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.05M 3,454 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$656k 3,454 shares
$189.87
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.7k 136 shares
$196.24
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $41.3k 136 shares
Last Trade
Feb 23, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.7k 136 shares
$196.24
$303.64
Forma Therapeutics Holdings
Forma Therapeutics Holdings FMTX
Director
Holding Value $0 0 shares
Last Trade
Oct 14, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$135k 6,750 shares
$20.01
$20.01
Forma Therapeutics Holdings
Forma Therapeutics Holdings FMTX
Director
Holding Value $0 0 shares
Last Trade
Oct 14, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$145k 7,250 shares
$20.01
$20.01
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $4.8 12,000 shares
Last Trade
Sep 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.7k 20,000 shares
$0.73
$0.00
Cyclerion Therapeutics
Cyclerion Therapeutics CYCN
Director
Holding Value $61.2k 20,000 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.24M 20,000 shares
$212.04
$3.06
Forma Therapeutics Holdings
Forma Therapeutics Holdings FMTX
Director
Holding Value $135k 6,750 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.3k 6,750 shares
$6.12
$20.01
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $7 17,500 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.7k 17,500 shares
$0.78
$0.00
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.56M 5,153 shares
Last Trade
May 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.32M 10,306 shares
$128.31
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $41.3k 136 shares
Last Trade
Feb 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.1k 136 shares
$147.47
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.22M 4,032 shares
Last Trade
Jul 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$693k 4,032 shares
$171.95
$303.64
Cyclerion Therapeutics
Cyclerion Therapeutics CYCN
Director
Holding Value $30.6k 10,000 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.9M 10,000 shares
$1,588.00
$3.06
Forma Therapeutics Holdings
Forma Therapeutics Holdings FMTX
Director
Holding Value $1.11M 55,282 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 11,125 shares
$25.35
$20.01
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $7 17,500 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$110k 17,500 shares
$6.30
$0.00
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.39M 4,581 shares
Last Trade
Jul 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$682k 4,581 shares
$148.77
$303.64
Forma Therapeutics Holdings
Forma Therapeutics Holdings FMTX
Director
Holding Value $1.05M 52,532 shares
Last Trade
Jun 23, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.16M 52,532 shares
$41.20
$20.01
Forma Therapeutics Holdings
Forma Therapeutics Holdings FMTX
Director
Holding Value $0 0 shares
Last Trade
Jun 23, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.8M 67,894 shares
$41.20
$20.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up